Literature DB >> 8195829

Structure-activity relationships of dihydrofolate reductase inhibitors.

K Bowden1, N V Harris, C A Watson.   

Abstract

Structure-activity relationships of antibacterial dihydrofolate reductase inhibitors are reviewed. A short introduction is followed by a more detailed review of developments since 1980. The design of site directed inhibitors based on data from X-ray crystallographic, NMR spectroscopy and molecular graphic studies is discussed. The development of quantitative structure-activity relations is surveyed from a historical point of view and these are contrasted with more recent alternative approaches. Conclusions are reached regarding possible future developments.

Mesh:

Substances:

Year:  1993        PMID: 8195829

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  7 in total

1.  Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae.

Authors:  V H Brophy; J Vasquez; R G Nelson; J R Forney; A Rosowsky; C H Sibley
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Correlation of trimethoprim and brodimoprim physicochemical and lipid membrane interaction properties with their accumulation in human neutrophils.

Authors:  M Fresta; P M Furneri; E Mezzasalma; V M Nicolosi; G Puglisi
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

3.  Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.

Authors:  Christina R Bourne; Richard A Bunce; Philip C Bourne; K Darrell Berlin; Esther W Barrow; William W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

4.  Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.

Authors:  W J Suling; L E Seitz; V Pathak; L Westbrook; E W Barrow; S Zywno-Van-Ginkel; R C Reynolds; J R Piper; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents.

Authors:  Vivek Srivastava; Ashutosh Kumar; Bhartendu Nath Mishra; Mohammad Imran Siddiqi
Journal:  Bioinformation       Date:  2008-06-27

6.  The structure and competitive substrate inhibition of dihydrofolate reductase from Enterococcus faecalis reveal restrictions to cofactor docking.

Authors:  Christina R Bourne; Nancy Wakeham; Nicole Webb; Baskar Nammalwar; Richard A Bunce; K Darrell Berlin; William W Barrow
Journal:  Biochemistry       Date:  2014-02-11       Impact factor: 3.162

Review 7.  Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.

Authors:  Christina R Bourne
Journal:  Antibiotics (Basel)       Date:  2014-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.